Bachelor of Guangxi University in 1982, master of cytogenetics of Purdue University in 1988, doctor of molecular biology of University of Wisconsin in 1991;
30 years of biomedical R & D and transformation experience after graduation, about 15 years of basic research PI in academia, benefited from the guidance of Nobel laureate Professor Roger Tsien, Professor Qian Yongjian and Professor Sydney Brenner, published more than 60 SCI academic papers, obtained more than 30 PCT patents, and trained 9 master's and doctoral students and 6 postdoctoral students at home and abroad;
About 15 years of R & D and transformation experience in the business community, including start-ups, senior scientists of Aurora Biosciences and research team leader of Futai Pharmaceutical (vertex, Dr. Joshua Boger, Borg as the founder), and participated in the early development of many new drugs on the market;
In October 2019, he became the general manager of Suzhou Yabao drug R & D company, responsible for the overall strategic layout of the company's new drug R & D, promoting the existing clinical projects and establishing a number of new drug projects; Suzhou is an innovative leader.
30 years of biomedical R & D and transformation experience after graduation, about 15 years of basic research PI in academia, benefited from the guidance of Nobel laureate Professor Roger Tsien, Professor Qian Yongjian and Professor Sydney Brenner, published more than 60 SCI academic papers, obtained more than 30 PCT patents, and trained 9 master's and doctoral students and 6 postdoctoral students at home and abroad;
About 15 years of R & D and transformation experience in the business community, including start-ups, senior scientists of Aurora Biosciences and research team leader of Futai Pharmaceutical (vertex, Dr. Joshua Boger, Borg as the founder), and participated in the early development of many new drugs on the market;
In October 2019, he became the general manager of Suzhou Yabao drug R & D company, responsible for the overall strategic layout of the company's new drug R & D, promoting the existing clinical projects and establishing a number of new drug projects; Suzhou is an innovative leader.
请将简历发送至：